| Primary |
| Hypertension |
39.3% |
| Product Used For Unknown Indication |
27.0% |
| Drug Use For Unknown Indication |
9.0% |
| Type 2 Diabetes Mellitus |
7.0% |
| Back Pain |
4.1% |
| Essential Hypertension |
2.0% |
| Hepatitis C |
1.6% |
| Depression |
1.2% |
| Urinary Tract Infection |
1.2% |
| Coronary Artery Disease |
0.8% |
| Diabetes Mellitus Non-insulin-dependent |
0.8% |
| Epilepsy |
0.8% |
| Hypertonia |
0.8% |
| Major Depression |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.8% |
| Pruritus |
0.8% |
| Accidental Exposure |
0.4% |
| Alcoholism |
0.4% |
| Analgesia |
0.4% |
| Antiinflammatory Therapy |
0.4% |
|
| Renal Failure Acute |
25.8% |
| Hyponatraemia |
9.1% |
| Vomiting |
7.6% |
| Embolic Stroke |
6.1% |
| Pyrexia |
6.1% |
| Hypertension |
4.5% |
| Hypotension |
4.5% |
| Inappropriate Antidiuretic Hormone Secretion |
4.5% |
| Condition Aggravated |
3.0% |
| Cough |
3.0% |
| Hyperglycaemia |
3.0% |
| Leukocytosis |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Chronic |
3.0% |
| Urinary Tract Infection |
3.0% |
| Vision Blurred |
3.0% |
| Weight Decreased |
3.0% |
| Accidental Exposure |
1.5% |
| Aldolase Increased |
1.5% |
| Blood Lactate Dehydrogenase Increased |
1.5% |
|
| Secondary |
| Hypertension |
34.8% |
| Product Used For Unknown Indication |
11.6% |
| Type 2 Diabetes Mellitus |
9.2% |
| Diabetes Mellitus |
5.1% |
| Drug Use For Unknown Indication |
4.4% |
| Coronary Artery Disease |
3.8% |
| Rheumatoid Arthritis |
3.4% |
| Hypertrophic Cardiomyopathy |
3.1% |
| Pain |
3.1% |
| Hypercholesterolaemia |
2.4% |
| Hyperuricaemia |
2.4% |
| Suicide Attempt |
2.4% |
| Bacterial Infection |
2.0% |
| Essential Hypertension |
2.0% |
| Osteoporosis |
2.0% |
| Toothache |
2.0% |
| Bladder Disorder |
1.7% |
| Ischaemic Stroke |
1.7% |
| Cerebrovascular Accident Prophylaxis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
|
| Renal Failure Acute |
28.3% |
| Pancreatitis Acute |
7.5% |
| Drug Interaction |
5.7% |
| Hyponatraemia |
5.7% |
| Arterial Thrombosis Limb |
3.8% |
| Hyperkalaemia |
3.8% |
| Hypoglycaemia |
3.8% |
| Inappropriate Antidiuretic Hormone Secretion |
3.8% |
| Joint Stiffness |
3.8% |
| Lichenoid Keratosis |
3.8% |
| Metabolic Acidosis |
3.8% |
| Neutropenia |
3.8% |
| Renal Failure Chronic |
3.8% |
| Retinal Vein Thrombosis |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| Anaemia |
1.9% |
| Arthralgia |
1.9% |
| Autoimmune Hepatitis |
1.9% |
| Cardiac Failure |
1.9% |
|
| Concomitant |
| Hypertension |
20.3% |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
15.2% |
| Diffuse Large B-cell Lymphoma |
6.2% |
| Type 2 Diabetes Mellitus |
5.4% |
| Diabetes Mellitus |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Prophylaxis |
3.9% |
| Hypercholesterolaemia |
3.2% |
| Pain |
2.9% |
| Acne |
2.1% |
| Hepatitis C |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Hiv Infection |
1.7% |
| Atrial Fibrillation |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Hypothyroidism |
1.4% |
| Osteoporosis |
1.3% |
| Anxiety |
1.2% |
| Restless Legs Syndrome |
1.2% |
|
| Myocardial Infarction |
12.1% |
| Weight Decreased |
11.1% |
| Vomiting |
9.1% |
| Dyspnoea |
7.1% |
| Panic Attack |
7.1% |
| Drug Ineffective |
5.1% |
| Malaise |
5.1% |
| Tachycardia |
5.1% |
| Drug Interaction |
4.0% |
| Pancreatitis Acute |
4.0% |
| Anaemia |
3.0% |
| Chest Pain |
3.0% |
| Eczema |
3.0% |
| Hepatitis Toxic |
3.0% |
| Hyperhidrosis |
3.0% |
| Injection Site Haematoma |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Nervous System Disorder |
3.0% |
| Oedema Peripheral |
3.0% |
| Pain |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
20.0% |
| Hypertension |
20.0% |
| Bipolar I Disorder |
10.0% |
| Osteoarthritis |
10.0% |
| Type 2 Diabetes Mellitus |
10.0% |
| Essential Hypertension |
6.7% |
| Pain |
6.7% |
| Arteriosclerosis Coronary Artery |
3.3% |
| Diarrhoea |
3.3% |
| Fibromyalgia |
3.3% |
| Parkinson's Disease |
3.3% |
| Prostatism |
3.3% |
|
| Angioedema |
8.3% |
| Asthenia |
8.3% |
| Atrioventricular Block |
8.3% |
| Dizziness |
8.3% |
| Drug Interaction |
8.3% |
| Hypocalcaemia |
8.3% |
| Hypoglycaemia |
8.3% |
| Hyponatraemia |
8.3% |
| Lactic Acidosis |
8.3% |
| Orthostatic Hypotension |
8.3% |
| Renal Failure Acute |
8.3% |
| Renal Failure Chronic |
8.3% |
|
